Page last updated: 2024-11-05

berkelium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Berkelium (Bk) is a synthetic actinide element. It was first produced in 1949 at the University of California, Berkeley, by bombarding americium-241 with alpha particles. Berkelium has no known stable isotopes, with the most stable being berkelium-247, which has a half-life of 1,380 years. Berkelium is a silvery-white metal that is highly radioactive and chemically reactive. It is primarily used in research, especially in the study of nuclear reactions and the properties of the actinide series. Berkelium's unique radioactive properties make it useful for a variety of applications, such as in nuclear medicine and in the development of new technologies. The study of berkelium and other actinides helps us understand the behavior of heavy elements and the structure of the atom, contributing to advances in nuclear chemistry and physics.'

Berkelium: A man-made radioactive actinide with atomic symbol Bk, atomic number 97, and atomic weight 247. Its valence can be +3 or +4. Twelve isotopes have been produced with mass numbers 240-251. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23971
CHEBI ID33391
MeSH IDM0002400

Synonyms (13)

Synonym
berkelium
7440-40-6
CHEBI:33391
berkelio
berkelium atom
97bk
bk
unii-2yqa718kuu
2yqa718kuu ,
berkelium [mi]
DTXSID70225389
DB12993
Q1882
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
actinoid atom
f-block element atom
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (90.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 72.26

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index72.26 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index118.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (72.26)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (8.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]